Cilcare
PrivateLast Round
Series A
Dec 4, 2024
Total Funding Raised
$46.84M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cilcare operates in Healthcare & Life Sciences and is based in Montpellier. Its latest recorded funding round was a Series A round in December 2024.
Cilcare is a biotechnology company that specializes in auditory sciences, providing research and development services and developing proprietary drug candidates for the treatment of hearing disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cilcare Comparables
Compare Cilcare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Turner Scientific | 77% | |
| PharmaLegacy | 65% | |
| Neuroservices-Alliance | 65% |
For institutional investors. Book with your work email.
Cilcare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 4, 2024 | ||||
| Grant | Jun 27, 2024 | ||||
| Pre Seed | Dec 1, 2014 | ||||
| Seed | Jul 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cilcare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofilaro | Seed, Series A |
| Shionogi & Co. | Series A |
| Créalia Occitanie | Pre Seed, Seed |
| SPRIM Global Investments | Series A |
| Occitanie Angels | Pre Seed, Seed |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 40% MoM.
- Jun 20, 2026
Monthly visitors grew 47% MoM, reaching 3.9K.
For institutional investors. Book with your work email.
Cilcare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cilcare's valuation, stock price, and market status.
Is Cilcare a public or private company?
Cilcare is a private company.
What is the current stock price of Cilcare?
Cilcare is a private company, so its shares have no public market price. Caplight tracks Cilcare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cilcare worth (valuation)?
Valuation information for Cilcare is not publicly available.
Can I buy Cilcare stock?
Cilcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cilcare's last funding round?
Cilcare's most recent funding round was Series A on December 4, 2024.
Who are the main investors in Cilcare?
Key investors in Cilcare include Sofilaro, Shionogi & Co., Créalia Occitanie, SPRIM Global Investments, Occitanie Angels.
Will Cilcare IPO soon?
No public IPO plans have been announced for Cilcare.
How can I track Cilcare secondary market activity?
Caplight tracks bids, offers, and trades in Cilcare's shares on secondary markets.